RadNet Shares Outstanding 2012-2026 | RDNT
RadNet shares outstanding from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
RadNet Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 75 |
| 2024 | 75 |
| 2023 | 65 |
| 2022 | 57 |
| 2021 | 53 |
| 2020 | 51 |
| 2019 | 50 |
| 2018 | 49 |
| 2017 | 47 |
| 2016 | 47 |
| 2015 | 45 |
| 2014 | 43 |
| 2013 | 40 |
| 2012 | 39 |
| 2011 | 39 |
|
RadNet Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-03-31 | 77 |
| 2025-12-31 | 75 |
| 2025-09-30 | 77 |
| 2025-06-30 | 76 |
| 2025-03-31 | 74 |
| 2024-12-31 | 75 |
| 2024-09-30 | 75 |
| 2024-06-30 | 73 |
| 2024-03-31 | 69 |
| 2023-12-31 | 65 |
| 2023-09-30 | 69 |
| 2023-06-30 | 61 |
| 2023-03-31 | 58 |
| 2022-12-31 | 57 |
| 2022-09-30 | 58 |
| 2022-06-30 | 57 |
| 2022-03-31 | 56 |
| 2021-12-31 | 53 |
| 2021-09-30 | 54 |
| 2021-06-30 | 53 |
| 2021-03-31 | 53 |
| 2020-12-31 | 51 |
| 2020-09-30 | 52 |
| 2020-06-30 | 51 |
| 2020-03-31 | 50 |
| 2019-12-31 | 50 |
| 2019-09-30 | 50 |
| 2019-06-30 | 50 |
| 2019-03-31 | 50 |
| 2018-12-31 | 49 |
| 2018-09-30 | 49 |
| 2018-06-30 | 49 |
| 2018-03-31 | 48 |
| 2017-12-31 | 47 |
| 2017-09-30 | 48 |
| 2017-06-30 | 47 |
| 2017-03-31 | 47 |
| 2016-12-31 | 47 |
| 2016-09-30 | 46 |
| 2016-06-30 | 47 |
| 2016-03-31 | 47 |
| 2015-12-31 | 45 |
| 2015-09-30 | 45 |
| 2015-06-30 | 45 |
| 2015-03-31 | 43 |
| 2014-12-31 | 43 |
| 2014-09-30 | 44 |
| 2014-06-30 | 43 |
| 2014-03-31 | 40 |
| 2013-12-31 | 40 |
| 2013-09-30 | 39 |
| 2013-06-30 | 40 |
| 2013-03-31 | 39 |
| 2012-12-31 | 39 |
| 2012-09-30 | 40 |
| 2012-06-30 | 39 |
| 2012-03-31 | 38 |
| 2011-12-31 | 39 |
| 2011-09-30 | 38 |
| 2011-06-30 | 40 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.302B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |